期刊文献+

影响急性脑梗死患者治疗效果的相关因素分析 被引量:42

Related factors of influence curative effects in patients with acute cerebral infarction
下载PDF
导出
摘要 目的探讨影响急性脑梗死患者治疗效果的相关因素。方法对360例急性脑梗死患者予以卒中单元规范化治疗;在治疗前、治疗14 d时进行美国国立卫生研究院卒中量表(NIHSS)评分,以及检测有关血常规、生化指标。采用多因素Logistic回归分析对与患者治疗后NIHSS评分相关的指标进行分析。结果与治疗前比较,脑梗死各亚组的血浆脂蛋白[Lp(a)]、尿酸、D-二聚体(D-D)、超敏C反应蛋白(hs-CRP)水平明显降低;轻、中度亚组血糖及中、重度亚组直接胆红素水平明显降低;中度亚组三酰甘油、低密度脂蛋白(LDL)及重度亚组总胆红素水平明显降低(均P<0.05)。重度亚组治疗前的血同型半胱氨酸(Hcy)水平明显高于轻、中度亚组(均P<0.05)。多因素Logistic回归分析显示,治疗后NIHSS评分与血糖、hs-CRP、Hcy、尿酸、D-D、LDL、Lp(a)水平相关(OR=1.235~4.042,P<0.05~0.001)。结论血糖、hs-CRP、Hcy、尿酸、D-D、LDL和Lp(a)为影响急性脑梗死患者治疗效果的相关因素。 Objective To explore the related factors of influence curative effects in patients with acute cerebral infarction(ACI). Methods Three hundred and sixty cases of ACI patients were given standardized treatment in stroke unit. The patients were scored with United States National Institutes of Health Stroke Scale ( NIHSS ) , and blood routine, biochemical indexes were measured before and 14 d after treatment. The related indexes with NIHSS scores after treatment were analyzed by logistic regression analysis. Results Compared with before treatment, the level of Lipoprotein(a) [ LP(a) ~, uric acid( UA), two D-dimer ( D-D), high sensitive C reactive protein (hs-CRP) were significantly decreased in each ACI subgroup; blood glucose in light, moderate subgroups and direct bilirubin in moderate, severe subgroups were significantly decreased ( all P 〈 0.05 ). The blood homocysteine (Hcy) levels in severe subgroup before treatment were significantly higher than that in light, moderate subgroups ( all P 〈 0. 05 ). The multivariate logistic regression analysis showed that NIHSS score after intervention treatment related with levels of blood glucose, hs-CRP, Hcy, UA, D-D, LDL and Lp (a) ( OR = 1. 235 - 4. 042,P 〈 0. 05 - 0. 001 ). Conclusion The blood glucose, hs-CRP, Hcy, UA, D-D, LDL and Lp(a) are related factors to influence the curative effects of ACI patients.
出处 《临床神经病学杂志》 CAS 北大核心 2013年第3期177-179,共3页 Journal of Clinical Neurology
基金 广西壮族自治区卫生厅项目(Z2009150)
关键词 急性脑梗死 干预治疗 疗效 acute cerebral infarction intervention therapy curative effects
  • 相关文献

参考文献9

  • 1Jia Q,Liu LP,Wang YJ. Stroke in China[J]. Clin Exp Pharmacol Physio1,2010 ,37 :259.
  • 2Wei JW,Arima H,Huang Y,et al. Variation in the frequency of in- tracerebral hemorrhage and ischemic stroke in China: a national, multicentre, hospital register study [J]. Cerebrovasc Dis, 2010,29 : 321.
  • 3中国急性缺血性脑卒中治疗现状[J].中华神经科杂志,2009,42(4):223-228. 被引量:100
  • 4王荣桂,董艳玲,蔺心敬等.急性缺血性脑梗死发病危险因素及其临床预测价值分析[J].中国老年病学杂志,2011,31:1852.
  • 5Song IU, Kim JS, Kim YI, et al. Relationship between high-sensitivi- ty C-reactive protein and clinical functional outcome 'after acute is- chemic stroke in a Korean population [ J ]. Cerebrovasc Dis,2009, 28:545.
  • 6Urabe T, Watada H, Okuma Y, et al. Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in Japanese patients[ J]. Stroke,2009,40 : 1289.
  • 7于艳春,杨柳,杨文,张艳华,刘柏辉,季有梅,徐丹,许桂英.老年脑梗死患者血清C反应蛋白水平的动态变化及临床意义[J].中国实验诊断学,2007,11(8):1046-1049. 被引量:5
  • 8王莉,张帆,张维健.急性缺血性脑血管病患者血清超敏C反应蛋白、血糖及外周血白细胞数的变化及临床意义[J].临床神经病学杂志,2011,24(6):469-469. 被引量:8
  • 9Silvestri A, Vitae C, Foxxetli F, et al. Plasma levels of inflammatory C-reactive protein and interleulcin-6 predict outcome in elderly pa- tients with stroke[ J]. J Am Geriatr Soe, 2004, 52 : 1586.

二级参考文献46

  • 1彭华,郭洪志.急性脑梗死及其并发多脏器功能障碍综合征患者血清C反应蛋白水平的变化[J].临床神经病学杂志,2004,17(5):330-332. 被引量:59
  • 2<脑卒中综合规范临床(内科)诊治研究方案>协作组.规范治疗急性脑卒中显著降低患者住院病死率[J].中华神经科杂志,2005,38(1):17-21. 被引量:74
  • 3高建国,周农,翟金霞.血清C反应蛋白水平与脑梗死预后的关系[J].临床神经病学杂志,2005,18(1):43-44. 被引量:113
  • 4Touze E, Mas JL, Rother J, et al. Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack : results from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Stroke, 2006, 37: 2880-2885.
  • 5Wardlaw JM, del Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, 3: CD000213.
  • 6Sacco RL, Chong JY, Prabhakaran S. Experimental treatments for acute ischaemie stroke. Lancet, 2007, 369:331-341.
  • 7Davalos A, Castillo J, Alvarez-Sabin J, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke, 2002, 33 : 2850-2857.
  • 8Albers GW, Goldstein LB, Hall D, et al. Aptiganel Acute Stroke Investigators. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA, 2001, 286:2673-2682.
  • 9Lees KR, Zivin JA, Ashwood T, et al. NXY-059 for acute ischemic stroke. N Engl J Med, 2006, 354: 5884500.
  • 10Ly JV, Zava|a JA, Donnan GA. Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke. Expert Opin Pharmacother, 2006, 7 : 1571-1581.

共引文献108

同被引文献360

引证文献42

二级引证文献432

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部